Highly multiplexed, patented and patent-pending GT-Plex™ PCR assays for low-level, reliable mutation detection These kits are for Research Use Only (RUO) Not for use in diagnostic purposes FORT COLLINS, Colo. — GT Molecular, Inc., a company providing ultrasensitive PCR assays for cancer research, pathogen detection, and wastewater-based epidemiology testing is entering the cancer molecular assay […]
RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and CeGaT GmbH, a global provider of sequencing services for research, clinical studies, and […]
AMSBIO announce MatriMix – a groundbreaking 3D culture substrate. This pioneering hydrogel sets a new benchmark in the field, containing fully defined components, including medical grade collagens, laminin-511 E8 fragments, and hyaluronic acid. The high lot-to-lot consistency of MatriMix enables researchers to obtain highly reproducible results. MatriMix overcomes the limitations of current 3D substrates, enabling cutting-edge applications such as […]
Company to host webinar featuring tips for managing large-scale proteomics data on UK Biobank Research Analysis Platform MOUNTAIN VIEW, Calif. — DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data access and companion analysis software, today announced its core platform and Cohort Browser are now optimized for accessing and analyzing large-scale proteomics […]
New Tapestri® v3 brings a higher number of cells captured and greater standardization and robustness to single-cell DNA and multi-omics workflows to empower customer success SOUTH SAN FRANCISCO, CA – Mission Bio, Inc. the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced breakthrough improvements to the Tapestri® Platform and its core chemistry that enable highly […]
RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and CeGaT GmbH, a global provider of sequencing services for research, clinical studies, and […]
DALLAS, TEXAS – Almaden Genomics has announced its Board of Advisors, a highly regarded group of healthcare leaders from both the public and private sectors with experience in cancer research, presicion medicine, biotechnology, clinical trials, bioinformatics, data visualization, computational analysis, pharmacology, and AI. The Board – which includes Adrian Lee, Ph.D., Samir Courdy; Rayna Herman; Graham […]
Up to an Additional $46.2 Million Available Through Warrant Exercise Led by Novalis LifeSciences LLC with participation from Northpond Ventures, M-185 Corporation and BroadOak Capital Partners SAN DIEGO — Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced it has signed a securities purchase […]
Getinge announces today an agreement to acquire 100% of the shares in High Purity New England, Inc. a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications. “This acquisition is another step in Getinge Life Science strategic journey to further expand our presence in the biopharma segment”, says Eric Honroth, President […]
Mediso Medical Imaging Systems recently installed a state-of-the-art 7T MRI at the University of Milano-Bicocca. The nanoScan® MRI 7T installed is equipped with a state-of-the-art cryogen-free superconducting magnet. Uniquely on the preclinical market, the pulse tube cryocooler is mounted at the back of the scanner to minimize vibrations thus delivering ghost-free images. The ultra-high magnetic field […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
